Multispeciality | |
255 S 17th St, Suite 2001, Philadelphia, PA 19103-6231 | |
(215) 546-7049 | |
(215) 546-8646 |
Full Name | Multispeciality |
---|---|
Type | Facility |
Speciality | Physical Medicine & Rehabilitation |
Location | 255 S 17th St, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023026416 | NPI | - | NPPES |
OS006039L | Other | PA | LIZERBRAM |
BB8177152 | Other | PA | BURCH |
DC006361L | Other | PA | ALSTON |
MD004666E | Other | PA | SPENCER |
Mailing Address | Practice Location Address |
---|---|
Multispeciality 255 S. 17th Street, Suite 2001, Philadelphia, PA 19103 Ph: (215) 546-7049 | Multispeciality 255 S 17th St, Suite 2001, Philadelphia, PA 19103-6231 Ph: (215) 546-7049 |
News Archive
In response to America's opioid crisis, public health departments and community organizations across the country have started to train opioid users to reverse overdoses in other users with the opioid-blocker naloxone.
Children living in Indian districts that are highly vulnerable to climate variability are more likely to suffer from malnutrition than those living in districts with very low vulnerability, a study suggests.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).
› Verified 1 days ago